The formation of epithelial tissues requires both the generation of apical-basal polarity and the coordination of this polarity between neighbouring cells to form a central lumen. During de novo lumen formation, vectorial membrane transport contributes to the formation of a singular apical membrane, resulting in the contribution of each cell to only a single lumen. Here, from a functional screen for genes required for three-dimensional epithelial architecture, we identify key roles for synaptotagmin-like proteins 2-a and 4-a (Slp2-a/4-a) in the generation of a single apical surface per cell. Slp2-a localizes to the luminal membrane in a PtdIns(4,5)P 2 -dependent manner, where it targets Rab27-loaded vesicles to initiate a single lumen. Vesicle tethering and fusion is controlled by Slp4-a, in conjunction with Rab27/Rab3/Rab8 and the SNARE syntaxin-3. Together, Slp2-a/4-a coordinate the spatiotemporal organization of vectorial apical transport to ensure that only a single apical surface, and thus the formation of a single lumen, occurs per cell.
cell has a single apical initiation site, and thus the tube has a single lumen, however, is largely unclear. Similarly, how such machineries are controlled at the transcriptional level during morphogenesis of epithelial tissues is poorly understood 3 .
Here, we report a functional screen for regulators of threedimensional (3D) epithelial polarity using MDCK cyst cultures, based on transcriptional, RNA-mediated interference (RNAi) and morphogenetic analysis.
Synaptotagmin-like proteins (Slps) 1-5 are a family of Rab effectors involved in regulated exocytosis 10 . Slps harbour an amino-terminal Rab-binding domain (also called the Slp homology domain SHD) and tandem carboxy-terminal C2 domains involved in Ca 2+ and phospholipid binding, and function in tethering secretory vesicles to the plasma membrane 11 . In Drosophila melanogaster, a single divergent Slp paralogue, bitesize (Btsz), functions in epithelial polarization 12 , although whether mammalian Slps function in polarity generation is unknown.
We demonstrate that Slp2-a and related family member Slp4-a function in distinct, but complementary, steps of apical transport Control  7B2  ARHGAP24  BST2  CDH16  CHE11  CLDN2  DAK  DYSF  FABP1  FARP1  FBLIM1  FGFR4  FRZB  FUZ  FXYD2  FYCO1  GAL4  GNB5  GRB7  IFT172  IGFBP6  IHH  JIP1  NGEF  NHERF1  NHERF2  NHERF3  PI3KR1  PI3KR2  PKIG  RANBPL3  RHOU  S100A4  S100A5  SEC14L3  SYTL2  SMTNL2  SNX2  SNX4  SNX5  STARD10  SYNGR1  SYT13  TB2/ (a) Experimental design for the function screen of regulators of 3D epithelial polarity. MDCK cells were cultured for 36 h in 2D or 3D (n = 3), and control (2D) and experimental (3D) RNA samples were analysed using the Affymetrix Canine Genome 2.0 platform. The significance of the data was determined by LiMMA analysis (false discovery rate (FDR) < 0.05). A set of significantly upregulated (>2-fold) genes was pooled with other genes of interest and then gene overexpression was validated by RT-qPCR. Bioinformatic pathway analyses revealed that some genes were connected in common functional pathways. A final set of 47 candidates was selected for stealth siRNA design. MDCK cells were transfected with siRNAs individually or in pools and cultured to grow cysts. The silencing efficiency of the siRNA was determined by RT-qPCR. Then, cells were fixed and stained for Podxl, β-catenin and nuclei to quantify normal lumen formation. The RNAi screening finally resulted in 16 positive hits (see Methods). (b) RNAi screening for polarization regulation. Lumen formation efficiency was quantified for each of the listed 47 siRNA treatments. Green dotted line, normal levels as found in control; red dotted line, the threshold considered for the definition of a positive hit (lumen formation < 75% of control; P < 0.05); green stars, positive hits; red dots, knockdowns where the efficiency was below 60%. * P < 0.05; n = 3; error bars represent s.d. (c) Examples of phenotypes induced by RNAi in the screen. Seventy-two hour MDCK cysts transfected with siRNA from four positive candidates (SMTNL2, CLDN2, RHOU and FUZ ) and stained for the apical marker Podxl (red), the basolateral marker β-catenin (β-cat; green), the tight junction marker ZO-1 (white) and nuclei (blue). Scale bars, 5 µm. (d) Epithelial cancers with a downregulated 3D polarity gene set. The expression levels of the candidate gene set in all cancer versus normal expression data sets were analysed using Oncomine (www.oncomine.org). The graph shows the number of downregulated genes per type of indicated epithelial cancers (P < 0.05,n varies in each tissue). (e) Frequency of gene downregulation in breast and kidney cancer data sets. The graph indicates the percentage of data sets with downregulated candidate genes in breast and kidney cancer versus normal tissue microarray data sets (Oncomine, P < 0.05). The yellow arrowheads denote genes downregulated in both breast and kidney cancer. to form a lumen de novo. Slp2-a controls the positioning of Slp4a/Rab27-positive vesicles to target exocytosis to a single PtdIns(4,5)P 2enriched lumen. Slp4-a regulates the tethering of these vesicles, through the association with the apical SNARE syntaxin-3 (Stx3), to mediate vesicle delivery to the lumen. Thus, through a functional, multi-step screen, we have identified a previously uncharacterized mechanism for coordinated vectorial transport, crucial to form a single apical domain.
RESULTS

Identification of 14 previously uncharacterized regulators of epithelial morphogenesis
We performed a multi-step, functional screen for regulators specifically of 3D epithelial architecture and morphogenesis. We first conducted a microarray-based differential expression analysis comparing the transcriptome of MDCK cells undergoing apical-basolateral polarization either in the traditional monolayer culture (2D), or as 3D cysts grown in basement membrane extract (3D), wherein MDCK cells self-assemble to form a 3D monolayer ( Fig. 1a ). Notable transcriptional differences were observed during 3D morphogenesis with 1,597 upregulated, and 1,304 downregulated probes detected ( Supplementary Fig. S1 ). To prioritize functional analyses, upregulated genes were subjected to bioinformatic analysis to reconstruct potential molecular pathways and known components of epithelial polarization. Using this approach, a set of 99 upregulated genes was selected for secondary validation by quantitative PCR (qPCR; Supplementary  Fig. S2 and Table S1 ). Finally, 47 candidate genes were targeted through short interfering RNA (siRNA), including the known polarity regulators claudin-2 (CLDN2) and Wrch-1 (RHOU ) as internal controls 13, 14 ( Fig. 1b and Supplementary Table S2 ). We found a set of 14 genes previously uncharacterized to be required for this process (Fig. 1b ,c, green stars and Supplementary Table S3 ). These included tight and adherens junctions, Rho GTPases, lipid signalling and membrane trafficking proteins.
To analyse a possible relevance of these genes in vivo, we analysed whether this gene set was downregulated in human cancers, suggesting an importance in the maintenance of a differentiated epithelial phenotype in vivo (Fig. 1d ). Notably, renal, breast and skin cancers presented with the strongest downregulation of this gene set. We selected one of these genes, SYTL2 (encoding the protein Slp2-a), which was significantly downregulated in several epithelial cancer data sets ( Fig. 1e ), to characterize its role in lumen formation.
Slp2-a associates with, and regulates the formation of, the luminal membrane
The mammalian Slp family has been shown to regulate primarily Rab27-dependent membrane trafficking and secretion [15] [16] [17] , but the function of these proteins in mammalian epithelial morphogenesis is unknown. We confirmed that Slp2-a protein levels were upregulated in 3D when compared with 2D cultures by western blot (14-fold enrichment at 72 h; Fig. 2a ), validating the qPCR data ( Supplementary  Fig. S2 ). Next, we characterized Slp2-a localization in MDCK cysts. On plating MDCK into 3D, the apical podocalyxin (Podxl) localized to the peripheral surface of early aggregates, before it is internalized into vesicles and delivered to the contact between two cells, where lumen is formed de novo 7, 9, 18 . In early aggregates, Slp2-a localized to the plasma membrane, enriched at cellular junctions ( Fig. 2b and Table 1 ). A pool of Slp2-a became apparent on internalized Podxl-positive transcytosing vesicles near the cell-cell contact (Fig. 2b , 16-20 h). On lumen formation (24-48 h), Slp2-a localized to the apical membrane ( Fig. 2b, 48 h) .
Slp2-a depletion perturbed 3D lumen formation in a dose-dependent manner ( Fig. 2c,e ), without affecting the cell polarity in cells growing in monolayers ( Supplementary Fig. S3A ). Slp2-a depletion results in abnormal morphology with multiple small lumens, and the accumulation of Podxl (Fig. 2d ), that we identify as transcytotic vesicles ( Supplementary Fig. S5C ). Notably, stable expression of RNAi-resistant human Slp2-a (GFP-Slp2-a; Fig. 2f 
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Slp2-a-3 siRNA: rescued lumen formation and morphogenesis of cysts with endogenous Slp2-a knockdown ( Fig. 2g ,h). Moreover, these results indicate that Slp2-a is the predominant variant required for epithelial morphogenesis in 3D-MDCK (ref. 19 ).
The SHD and C2 domains play non-redundant roles in targeting Slp2-a to membranes
Slp-family proteins share an N-terminal Rab27-binding domain (the SHD), a linker region and two c-terminal tandem C2 domains (phospholipid and/or protein interaction sites) 20, 21 . Slp2-a could potentially therefore connect Rab GTPases and phosphoinositides during lumen formation [7] [8] [9] . To elucidate the control of Slp2-a localization, we analysed Slp2-a domains during cyst formation. In early aggregates, the C2 domains localized to the plasma membrane and to cell-cell junctions, but not to Podxl vesicles ( Fig. 3a and Supplementary Fig. S4b , 12-20 h). Once lumens formed, the C2A/B fragment localized exclusively to the apical membrane ( Fig. 3a and Supplementary Fig. S4b , 24-48 h). In contrast, the SHD fragment was predominantly cytoplasmic, and partially localized to Podxl vesicles in early aggregates and subapically in mature cysts (Fig. 3a , bottom panels). Deletion of the C2 domains (GFP-Slp2-a C2A/B ) resulted in a similar localization to the SHD, whereas the linker region was cytoplasmic ( Supplementary Fig. S4 ). These results suggest that whereas the SHD binds to apical vesicles, the C2 domains target Slp2-a to membranes.
Notably, the distribution of the C2 domains resembles PtdIns(4,5)P 2 localization during cyst formation 9 . Furthermore, Slp2-a, and paralogues, bind selectively to PtdIns(4,5)P 2 (refs 12,17) , although it could bind also to phosphatidylserine 16 . We found that C2 domains bound specifically to PIP 2 species, but not to phosphatidylserine ( Fig. 3c ). Lact-C2-GFP, a probe for phosphatidylserine, presents non-polarized membrane localization in cysts ( Supplementary Fig. S4e ). Given the established role of PtdIns(4,5)P 2 in apical membrane specification 9 , and higher cellular abundance 22 , we reasoned that PtdIns(4,5)P 2 may target Slp2-a to plasma membranes. During cyst formation, Slp2-a and PtdIns(4,5)P 2 co-localized at the plasma membrane, becoming progressively enriched to the lumen in morphogenesis ( Fig. 3d ). Both PtdIns(4,5)P 2 and Cherry-Slp2-a disappeared rapidly from the apical membranes on ionomycin treatment, which causes PIP depletion at the membrane 23 ( Fig. 3e and Supplementary Video S1). Taken together, these results confirm that Slp2-a requires the C2 domains for PtdIns(4,5)P 2 binding and apical membrane localization, whereas the SHD region targets Slp2-a to apically destined vesicles ( Fig. 3f ).
Slp2-a targets Rab27 vesicles to the lumen initiation site to form the lumen
Nearly all described functions of mammalian Slps required the SHD domain 21 . In contrast, Btsz, the sole Slp paralogue in Drosophila, does not require a Rab-binding domain for epithelial Fig. S5b ), suggesting Rab-Slp interactions may be dispensable for epithelial polarity. To address this possibility, we expressed the epithelial Btsz protein (Btsz2-GFP)
and an SHD-deleted Slp2-a mutant (GFP-Slp2-a SHD ). Importantly, neither GFP-Slp2-a SHD nor Btsz2-GFP was able to rescue the defects caused by endogenous Slp2-a knockdown (Fig. 4a-c and Supplementary Fig. S4b ) . These results reveal that the SHD region is required for epithelial morphogenesis in MDCK cysts.
To determine which Rab GTPase interactions are required for Slp2-a function, we analysed Rabs that interact with other Slps (ref. 10 ). Slp2-a bound to Rab3b, Rab8a, Rab27a and to a lower extent Rab3a ( Supplementary Fig. S5A ). Although Rab8a/b are required for cyst formation 7, 18 , only knockdown of both Rab27a/b strongly perturbed lumen formation ( Fig. 4d-g) , confirming partial isoform redundancy noted from knockout mice 24 . In contrast, although Rab3a-d isoforms are expressed in MDCK (data not shown), silencing of Rab3b was sufficient to disrupt cyst formation ( Fig. 4d-g ), suggesting Rab3b may have subtle non-redundant roles in apical transport 25, 26 , and epithelial polarity. These results suggested that Slp2-a could mediate the targeting of apical vesicles loaded with Rab27a/b, Rab3b and/or Rab8a/b.
Next, we generated Slp2-a SHD mutants to disrupt the interaction with specific Rabs based on the structure of the Slp2-a/Rab27 interaction 20 . The introduction of a V18A mutation in Slp2-a completely abolished the interaction with Rab3b and Rab8a, while preserving Rab27a binding; E11A/R32A mutations also disrupted the binding to Rab27 (Fig. 4g ). Although both mutants retain apical localization ( Fig. 4i and Table 1 ), GFP-Slp2-a V18A , but not GFP-Slp2-a E11A/R32A , completely rescued the Slp2-a knockdown phenotype (Fig. 4h ,i and Supplementary Fig. S5f ). Together, these data indicate that although Slp2-a can bind multiple Rabs, Rab27a/b is necessary and sufficient for Slp2-a function in lumen morphogenesis.
Next, we analysed Rab27 localization. Before lumen formation, GFP-Rab27a co-localized with Podxl and Slp2-a in vesicles transcytosing to the lumen (Fig. 4j , top and middle panels and Supplementary Fig. S5c ). Once lumen initiation was completed, Rab27a localized to a subapical compartment, whereas Slp2-a localized apically (Fig. 4j , bottom panels and Supplementary Fig. S5c,e ). Finally, Slp2-a knockdown caused the scattering of Rab27a vesicles close to the plasma membrane (Fig. 4k , bottom panels). Thus, Slp2-a is required to localize Rab27a. Taken together, these results indicate that Slp2-a binds to Rab27a-loaded apical vesicles and targets them to initiate the lumen.
Slp4-a also functions in lumen biogenesis
In addition to Slp2-a, mammalian cells express four other Slp-family proteins (Slp1-5), and four closely related Slac2s (Slp homologue lacking C2 domains) 10 . To determine whether other Slp proteins function in epithelial polarization, we analysed their expression during lumen formation. Notably, whereas Slp2-a was the sole Slp upregulated in 3D at early times ( Fig. 5a , 3D-14 h), Slp1 and Slp4-a were upregulated at later times ( Fig. 5a , 3D-36 h).
In contrast to Slp1, Slp4-a silenced cysts presented acute defects with the formation of multiple lumens and internal vesicles (Fig. 5b,c ). In addition, Slp4-a knockdown did not affect polarity or ciliogenesis in monolayers ( Supplementary Fig. S3a,b) . Moreover, we observed that Slp2-a is specifically induced before Slp4-a in 3D cultures ( Fig. 5d ), suggesting that Slp2-a is required earlier than Slp4 in lumenogenesis.
We next examined the localization of Slp4-a. Endogenous Slp4a/b and GFP-Slp4-a associated with apical membranes at all stages of polarization ( Fig. 5e and Supplementary Fig. S6d ), thus presenting a different localization pattern from Slp2-a ( Fig. 3 and Table 1 ). Next, we examined Slp4-a domains in cysts. The C2 domains (C2A/B), either alone or in tandem, localized to apical and basolateral plasma membranes ( Fig. 5f , left panels, Supplementary Fig. S6e and Table 1 ), suggesting that they confer nonspecific plasma membrane localization. In support of this, GST-Slp4-a C2 domains bound promiscuously to PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 (Fig. 5g,h and Supplementary  Fig. S6c ). In contrast, the C2A domain of Slp2-a bound specifically to PtdIns(4,5)P 2 and localized apically ( Supplementary Fig. S4d ), suggesting that only Slp2-a is able to tether Rab27 vesicles to apical PtdIns(4,5)P 2 -enriched plasma membrane. Together, these data highlight a requisite of the SHD-linker region for apical targeting of Slp4-a, representing a major difference from Slp2-a, and suggesting non-redundant roles for Slp2-a and Slp4-a in lumen formation.
Slp4-a apical localization and function depend on Rab and syntaxin interaction
Slp4-a functions in docking of secretory granules with the plasma membrane, a function modulated by the SHD region, which interacts with Rab3, Rab8 and Rab27 family members 10 . Therefore, we examined the contribution of Rab binding to Slp4-a function.
To elucidate the role of Rab binding, we examined the ability of SHD mutations to bind to Rab27/3/8 and to rescue the phenotype of endogenous Slp4-a knockdown (Fig. 6a,b) 27 . In contrast to apical wild-type (WT)-Slp4-a, removal of the Rab-interacting region of Slp4-a SHD resulted in both cytoplasmic and non-polarized membrane localization of Slp4-a ( Fig. 6c, Supplementary Fig. S6e and Table 1) , as for Slp4-a W118S (no Rab binding) expression ( Fig. 6a-c , Supplementary  Fig. S6f and Table 1 ). Uncoupling of Slp4-a from Rab3b (V21A) resulted in subapical localization ( Fig. 6c and Supplementary Fig. S6f ). In contrast, co-uncoupling of Rab8 and Rab3b (I18A) resulted in the targeting of a pool of Slp4-a to the basolateral membrane, in addition to subapical vesicles ( Fig. 6a-c, Supplementary Fig. S6f and Table 1 ). Whereas WT-Slp4-a was able to rescue endogenous Slp4-a knockdown, none of the Rab-binding mutants was able to restore lumen formation (Fig. 6b,c and Table 1 ). These results indicate that Rab27, Rab8 and Rab3 binding are required for Slp4-a localization and function. The different localization of the mutants also suggests that Rab27 is required for Slp4-a targeting to vesicles, Rab8 would be necessary to exclude Slp4-a from the basolateral membrane, and Rab3 may be important for subsequent Slp4-a transport to the lumen initiation membrane.
Next we analysed the role of phospholipid binding for Slp4-a, using a phospholipid-uncoupled mutant (K > Q; ref. 16 ). Slp4-a K>Q localized to subapical puncta of apical membranes ( Supplementary Fig.  S6g and Table 1) , and conferred a partial rescue to morphogenesis ( Fig. 6b ), suggesting that although the C2 domains can confer membrane localization, interaction of Slp4-a with other factors (Rabs and SNARE complexes) may partially compensate for the lack of C2 domain function.
Slp4, in contrast to other Slps, binds to SNARE proteins by its linker domain 28, 29 . To analyse SNARE binding, we generated a chimaeric construct of Slp4-a bearing a Slp5 linker domain (Slp454) that was unable to bind to Stx3 (Fig. 6d ). Slp454 showed a subapical and basolateral localization, and failed to rescue lumen formation on endogenous Slp4-a knockdown (Fig. 6e,f and Supplementary Fig. S6i and Table 1 ), suggesting an important role for Stx3 binding to Slp4-a. Next, we mapped the Stx3-binding domain of Slp4-a, and Supplementary  Fig. S9 . identified amino acids 305-354 to be essential for Stx3 binding ( Supplementary Fig. S6h ). Consistently, expression of a construct lacking amino acids 305-354 of Slp4-a (GFP-Slp4-a 305 -354) also failed to localize to the apical plasma membrane and to rescue lumen formation on endogenous Slp4-a knockdown ( Fig. 6e and Supplementary Fig. S6j and Table 1 ).
Stx3 functions as a critical apical 30 SNARE. In cysts, GFP-Stx3 co-localized with Slp4-a at the nascent luminal membrane (Fig. 6g) . Notably, Stx3 knockdown resulted in disruption of lumen formation and the redistribution of a pool of GFP-Slp4-a to the basolateral membrane ( Supplementary Fig. S6i-k) , and a similar localization observed on the removal of the Stx-binding region of Slp4-a ( Supplementary Fig. S6i,j) . In contrast, Slp4-a knockdown did not disrupt the apical localization of Stx3 (Fig. 6h) . These data suggest that Stx3 association with Slp4-a, by interaction with the linker domain, directs recruitment of Slp4-a to apically destined vesicles, and initiation of de novo lumen formation.
Slp2-a regulates Slp4-a function to produce a single apical surface per cell
Our data thus far indicate that Slp2-a and Slp4-a function in distinct, non-redundant steps in Rab-dependent transport to form the lumen. We thus examined their localization during lumen formation. In early aggregates, Slp2-a localized mainly to cell-cell junctions, whereas Slp4-a co-localized with Podxl at the cell-extracellular matrix interface (Fig. 7a, 16 h, top panels and Supplementary Fig. S7c ).
As internalized Podxl transcytosed to the cell-cell contact, Slp4-a co-localized to these vesicles, whereas Slp2-a was mainly at the cell-cell junctions (Fig. 7a, 20 h and Supplementary Fig. S7c ). Finally, Slp2-a/4-a co-localization was evident once lumens formed (Fig. 7a, 24 h and Supplementary Fig. S7c ).
Next we examined whether their activities were mutually dependent. Knockdown of Slp2-a caused the scattered distribution of small Podxl vesicles and the redistribution of GFP-Slp4-a to the lateral plasma membrane, partially co-localizing with Podxl vesicles (Fig. 7b,  arrows) . In contrast, Slp4-a knockdown cysts presented clusters of Podxl vesicles (Fig. 7c ), but GFP-Slp2-a localized normally to cell-cell contacts, suggesting that Slp2-a localization and function are independent, or upstream, of Slp4-a. Furthermore, overexpression of GFP-Slp2-a forced endogenous Rab27a and Slp4-a mis-recruitment to cell-cell contacts at early time points (Fig. 7d) , whereas the converse effect of GFP-Rab27a on Slp2-a was not observed (not shown). These results suggest that Slp2-a functions to regulate the positioning of Rab27 vesicles upstream of Slp4-a-mediated vesicle docking, thus controlling the position of the apical membrane and subsequent lumen.
To test this hypothesis, we silenced Slp2-a and Slp4-a alone or together ( Fig. 7e-g) . Strikingly, we observed that whereas Slp4-a knockdown induced accumulation of Podxl vesicles close to the membrane (Fig. 7e, middle panels) , Slp2-a knockdown cysts possessed some cells simultaneously developing more than one apical membrane (Fig. 7e , top panels, quantification Fig. 7g ). Moreover, although dual knockdown cysts presented a mixture of both phenotypes (Fig. 7e, bottom panels) , they perturbed single lumen formation to a level resembling that of Slp4-a knockdown alone, supporting the notion that Slp4-a functions downstream of Slp2-a (Fig. 7f ). Although cysts with multiple lumens have been observed previously on knockdown of trafficking proteins, the knockdown of Slp2a is unique in that this is the first time, to our knowledge, that a cell can participate simultaneously in the generation of multiple luminal surfaces.
These results indicate that Slp2-a and Slp4-a form part of a core apical transport pathway that controls the positioning of Rab27a/b vesicles, and their subsequent Rab8/Rab3b/Stx3-dependent fusion with the apical plasma membrane, respectively, to form a single PtdIns(4,5)P 2 -enriched apical membrane and lumen during de novo apical domain biogenesis (Fig. 7h ).
DISCUSSION
One of the central, unsolved questions in epithelial biology concerns how apical-basolateral polarity is coordinated between neighbouring cells to form a common, single luminal region. Making use of the fact that MDCK can undergo polarization into either in 2D or 3D, we have uncovered a gene set that specifically facilitates the transition to the 3D architecture. Interestingly, most of this gene set is downregulated in some glandular epithelial cancers, indicating a potential clinical relevance in maintaining a polarized phenotype (Fig. 1) .
During the development of 3D polarity, apical membrane components are delivered to the site for lumen initiation, between neighbouring cells, to initiate a luminal space de novo 7, 31 . What had remained unclear, though, was how this trafficking pathway was organized to direct vectorial transport to a singular position, thus allowing formation of a single apical membrane per cell. Here, we have identified a molecular pathway specifically upregulated during 3D morphogenesis that controls the formation and positioning of a single apical membrane per cell, through the complementary functions of Slp2-a and Slp4-a (Fig. 7h ). We demonstrate that Slp2-a controls the clustering of apically destined vesicles through the interaction with Rab27a/b and the association with PtdIns(4,5)P 2 at the nascent apical membrane. Subsequently, Slp4-a acts as an effector of Rab27a/b, Rab8a/b and Rab3b on vesicles, to couple the vesicles to Stx3-mediated fusion events at the plasma membrane to create the lumen. Inhibition of this Slp2-a/4-a pathway perturbs this transport and ultimately causes the formation of multiple apical membranes. These data support our model that Slp2-a and Slp4-a function in a spatiotemporal cascade to control vectorial apical transport (Fig. 7h) , a fact supported by their sequential transcriptional upregulation during cyst formation.
An interesting question is how Slp2-a/4-a may coordinate this vectorial transport to form a single lumen. In non-polarized cells, both Slp2-a and Slp4-a are considered as negative regulators of secretion, on the basis of the fact that their overexpression attenuates secretory granule release [15] [16] [17] 27, 32 . Indeed, Slp4-a can interact with the closed (non-fusion-forming) conformation of SNARE complexes 29 . To this end, transient overexpression of Slp2-a or Slp4-a in the presence of endogenous protein consistently reduced single-lumen-formation rates ( Supplementary Fig. S7A,B) , a trend that could be strongly reversed by expression of SHD-deleted Slp2-a/4-a, suggesting that they may act as negative regulators of vesicle trafficking. However, Slp2-a/4-a are also clearly required for single lumen formation, thus suggesting a scenario where, rather than being considered as negative or positive regulators of exocytosis, Slp2-a/4-a act as molecular traffic wardens 32 , controlling vectorial exocytosis through ensuring vesicles dock and fuse only at singular membrane domains to form a single, coordinated luminal space between neighbouring cells.
We identified, for the first time, a transcriptionally regulated molecular pathway that controls the formation of a single apical surface per cell, addressing a major, long-term unanswered question in cell biology. The study of the transcriptional machinery responsible for lumenogenesis in vivo presents a major future challenge to both cell and developmental biology.
METHODS
Methods and any associated references are available in the online version of the paper.
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METHODS
Two-step functional screening (microarrays, RT-qPCR, RNAi, Oncomine).
A microarray-based differential expression analysis was conducted using the Affymetrix Canine Genome 2.0 platform. MDCK type II cells were grown in P100 dishes to form 2D monolayers or 3D cysts in Matrigel (at 10 5 cells ml −1 ). Total RNA was isolated at 36 h and purified using RNeasy (Qiagen) and 5 µg of RNA was submitted for microarray analysis (n = 3) using the Affymetrix platform at Parque Científico de Madrid (Cantoblanco). The raw microarray data are deposited in NCBI GEO (Gene Expression Omnibus), accessible online using the number GSE32495. A LiMMA (false discovery rate < 0.05) analysis revealed a set of 1,597 upregulated genes. The resulting data set was analysed to select a maximum of 100 upregulated genes for qPCR validation. To further examine this selection, we used bioinformatic/bibliographic searches to analyse all 1,597 upregulated genes for previously published references into function, and Gene Ontology terms from human or mouse orthologues in NCBI databases. We selected genes with Gene Ontology terms, or references into function related to processes or mechanisms involved in changes in cell signalling, cell architecture and organ morphogenesis.
The list included a comprehensive list of Gene Ontology terms related to cell polarity, membrane trafficking, cell-to-cell junction assembly and remodelling, cell cycle regulation, cytoskeleton regulation and cell division, among others (complete list on demand). The second selection approach used STRING software (http://string-db.org/) to select genes interacting with pathways previously known to have a role in epithelial architecture or morphogenesis. From the resulting list, we selected 99 genes on the basis of bibliographic research and designed specific primers to perform qPCR analysis validation of their overexpression pattern in 3D cyst formation.
After qPCR validation, a stealth siRNA library was custom designed to target 47 validated candidate genes (Invitrogen). To perform the siRNA screening, MDCK cells were transfected with siRNA using Nucleofector-II (Lonza). Transfected cells were cultured for two days in 3D conditions and RNA extracts were analysed by RT-qPCR to check the silencing efficiency ( Supplementary Table S2 ). Gene expression silencing was verified by RT-qPCR procedures (SYBR RT-qPCR premix, Applied Biosystems), and normalizing to GAPDH or HPRT expression. For functional analyses, transfected MDCK cells were grown for three days in Matrigel to form cysts, and lumen formation efficiency was quantified by confocal microscopy using the following markers to assess lumen formation: localization of the apical protein Podxl, integrity of the actin cytoskeleton (F-actin; phalloidin), adherens junctions (β-catenin), tight junctions (ZO-1), nuclei (DNA; DAPI).
Antibodies. Antibodies against α-tubulin (1:5,000; T9026, Sigma-Aldrich), Rab27a
(1:200; R4655, Sigma-Aldrich), GFP (1:500; a5455, Invitrogen), Rab8a (1:1,000, 610845, BD Biosciences), mRFP/Cherry (1:250; PM005, MBL), Stx3 (1:200; Ab4113, Abcam), GST (1:5,000; sc138), β-catenin (1:1,000, sc7199) and Slp4-a (1:100; 34448) from Santa Cruz Biotechnology were commercial primary antibodies. The Slp2-a antibody was raised as a polyclonal serum against the Slp2-a SHD region and used as previously described 33 . Podxl antibody was a gift from the Ojakian laboratory (State University of New York Downstate Medical Center, USA). ZO-1 (1:500; R4076) was from DSHB. Peroxidase-conjugated donkey anti-mouse IgG and anti-rabbit IgG were used as secondary antibodies for western blots (Jackson ImmunoResearch Laboratories). Alexa Fluor-conjugated secondary antibodies (Alexa Fluor 405, 488, 555 or 647; Invitrogen) and TOPRO-3 or DAPI (for nuclear/DNA staining) were used in the microscopy protocols.
Plasmids. Slp2-a and Slp4-a (full length and mutants) were cloned into either pEGFP-C1/C2 or pmCherry-C1 vector (Takara Bio). The human Slp4a complementary DNA template was from Open Biosystems (Thermo Fisher). Plasmids provided were: pEGFP-Slp1 (J. Peränen, University of Helsinki, Finland), pEGFP-STX3a (M. ter Beest, University of Chicago, Illinois, USA), pENTR-Rab3a/b/c/d (B. Goud, Institut Curie, Paris, France), pEGFP-Rab8a (M. Montoya, CNIC, Madrid, Spain) and pEGFP-Rab27a/b (WT and dominant negative) (J. Hammer, NIH, USA). For bacterial expression of GST-tagged full-length and mutant proteins, Slp2-a and Slp4-a were cloned into pGEX-4T1 vector (Promega) or pDEST15 (Invitrogen). Slp2-a (V18A, E11A/R32A; ref. 16) , and Slp4-a (V21A, W118S, I18A, K > Q; refs 17,27) mutants were generated using Quickchange XL (Stratagene). To disrupt C2 domain-lipid interactions in Slp4-a (C2AB K > Q; K410Q, K412Q, K416Q, K564Q, K566Q, K571Q), three of four lysine residues of the PIP-binding consensus motifs present in synaptotagmin and synaptotagmin-like family C2 domains [K(K/R)KTXXK(K/R)] were mutated to glutamine in both C2 domains, as reported for Slp2-a (ref. 16 ). To disrupt Stx interactions in Slp4-a, the linker domain of Slp4-a was substituted for the linker domain of Slp5 (GFP-Slp454a) by subcloning the chimaeric SHD Slp4 -linker Slp5 fragment from a previously reported Slp454b construct 28 into a GFP-Slp4-a C2AB plasmid. T7-tagged Slp4-a, Slp454a and Slp4-a linkers were used for in vitro Stx3 binding experiments as previously reported 28, 29 . The Slp4-a construct lacking the Stx3-interacting amino acids of the linker domain ( 305-354) was cloned into pEGFP-C1. All constructs were verified by sequencing.
Cells and 3D culture. T23-MDCKII and MDCKII cells were grown as described previously 9 . MDCK cells stably expressing GFP-Slp2-a (full length and mutants), Cherry-Slp2-a, GFP-Rab27a, GFP-Rab8a and PLCδ-PH-GFP (PHD-GFP) were made by co-transfection with the blasticidin-resistant gene and selected for ten days with 0.5 µg ml −1 blasticidin. MDCK cells stably expressing GFP-Slp1, GFP-Stx3 or GFP-Slp4-a (full length and mutants) were selected for ten days using G418 (0.5 mg ml −1 ). Cysts and Transwell cultures were prepared as described before 34 .
Microscopy. Immunofluorescence microscopy of cysts was performed as previously described 9, 34 . Per condition, >100 cysts per experiment were analysed. For early time points, cysts were grown up to 24 h and two/three-cell stage cysts were classified on the basis of Podxl and β-catenin localization either as: formed preapical-patch or presence of internal vesicles.
RNAi. The RNAi sequences and qPCR primers are listed in Supplementary Table S3 .
Briefly, 25 nucleotide stealth siRNA duplexes targeting messenger RNA sequences of canine Slp2-a were purchased from Invitrogen. Sequences were submitted to BLAST search to ensure targeting specificity. For siRNA transfection, MDCK cells were trypsinized and then nucleofected (Lonza) with siRNA duplexes or scrambled siRNA. After 24-h incubation, cells were resuspended and plated in 12-well plates and in coverglass chambers coated with Matrigel to grow cysts. Total cell lysates from 3D cultures were analysed by western blotting or RT-qPCR to confirm the siRNA efficiency.
Stable RNAi was achieved by viral short hairpin RNA (shRNA), essentially as previously described 7 . In all instances, knockdown was verified by western blot or RT-qPCR procedures (Brilliant-II SYBR Green Kit, Agilent), and normalizing to GAPDH expression. RNAi and RT-qPCR primers are presented in Supplementary  Table S3 . Stx3 shRNA is as described previously 35 . Slp1 and Slp4-a shRNA lentiviruses were constructed in pLKO.1-puro according to the Addgene pLKO.1 protocol (www.addgene.org) using iRNAi (www.mekentosj.com), and target sequences were based on an (AA)N19 algorithm. RNAi sequences were submitted to BLAST (NCBI) to verify target specificity, with SYTL4 sequences targeting common regions to Slp4-a and Slp4-b transcripts. GFP-tagged human Slp4-a, which is not targeted by anti-canine shRNA, was used for Slp4-a knockdown and rescue experiments.
Virus production and transduction. Lentivirus production was performed essentially as previously described 7 . For lentivirus transductions, subconfluent MDCK cultures, 1-4 h after plating, were infected with virus-containing supernatants for 12-16 h at 37 • C. Viral supernatants were then diluted 1:1 with growth medium, and cultured for a further 48 h. Transduced cells were selected by passage into appropriate antibiotic-containing medium. Puromycin (5 µg ml −1 ), and blasticidin (12.5 µg ml −1 ) were used.
Statistics.
Single lumen formation was quantified as previously described 7 . The percentage of cysts with a single lumen was determined, and normalized to control cysts as 100%. Values are mean ± s.d. from ≥3 replicate experiments, with n ≥ 100 cysts per replicate. For RT-qPCR experiments, the percentage of remaining mRNA in each knockdown condition was normalized to the HPRT level, and represented as a percentage of the control (scramble shRNA) mRNA levels. The significance was calculated using a paired, two-tailed Student's t -test. * P < 0.05, * * P < 0.001.
Rab-GTPase pulldown. Rab GTPase-Slp protein pulldowns were performed using HEK293T cells overexpressing GFP-tagged Rab proteins, and GST-tagged Slp proteins. HEK293T cells expressing GFP-tagged Rab proteins were lysed in 0.1% SDS, 1% Triton X-100, 0.5 mM dithiothreitol and ×1 TBS buffer with a protease inhibitor cocktail and sodium orthovanadate. Cell debris and nuclei were removed by centrifugation at 14,000g for 2 min at 4 • C, and lysates were precleared and incubated in rotation with 100 ng of the relevant GST protein-loaded beads (GE Amersham) for 30 min, using GST alone as the control, in the presence of a non-hydrolysable GTP analogue (Sigma). Beads were centrifuged and washed five times, dried using aspiration, and resuspended in 40 µl Laemmli buffer before western blot analysis.
Co-immunoprecipitation assays. Co-immunoprecipitation assays in COS-7 cells were performed essentially as described previously 28, 29 . In brief, pEF-FLAG-Stx3, pEF-FLAG-Munc18-2, pEF-T7-Slp454 (a linker domain-swapping construct between Slp4-a and Slp5 (ref. 1,5  2  2,5  3  3,5   7B2  ADRBK2  ANKRD28  AQP5  ARL3  AXUD1  BREVIN  BST2  CADM1  CAMK1D  CASC4  CHE11  CiB1  CLD2  DAK  DIRC2  DLG2  DP1  DYNLC2B  DYSF  EFCAB1  EFCAB10  FBLIM1  FGFR4  FRZB  FXYD2  FYCO1  GAL3  GNB5  HECW2  HHAT  HINT2  ICK  IFT172  IFT74  IP6K2  JIP  KIF5B  MUC20  MYADM  MYO18A  NHERF1  NHERF2  OCIN  PCM1  PIK3R2  PKIG  PLLP2  PTPLAD2  RAB10  S100A13  S100A4  S100P  SEC10  SEC62  SMTNL2  SNX17  SNX2  SNX4  SNX5  STX1B  SYNGR1  SYNJ2BP1  TMEM205  TSPAN8  VAMP1  VAPB  VLA6  VPS37D  WBSCR16   2D 36h   3D 14h   3D 36h   0  1  2  3  4  5  6  7  8 at 4ºC, after washing, they were grown for 24 hours more, allowing lumen development to occur. Then, they were fixed and staining for b-catenin (blue) and a secondary antibody to detect the uptaken α-GFP. Inmediately after binding (14h), control and Slp2-a silenced cysts showed peripheral GFP-PCX (green) and α-GFP (red). 24 hours after treatment, control cysts presented podocalyxin, mainly in the apical plasma membrane (arrows), revealing PCX-GFP is transcytosed from peripheral membranes to the new developed apical membrane. However, Slp2-a knock-down cysts showed accumulations of vesicles containing GFP-PCX (green) and α-GFP (red), suggesting a defect in trafficking of transcytosed PCX. Yellow, colocalization of podocalyxin and bound antibodies, blue indicates b-catenin. Bar, 10 mm. (F) Quantification of antibody localization after uptake in control or Slp2-a KD cysts. Cysts in Figure A were analyzed by confocal microscopy. Cysts were classified as "vesicles", "apical plasma membrane" (APM) or "not-internalized" depending on the localization presented by the α-GFP (Red) antibody was found in internal vesicles, apical membrane or peripherally, respectively. Values are mean ± SD from three different experiments. N=3 (>100 cysts/ experiment; **, P < 0.005; *, P<0.05). Cells were plated to form cysts for 20-24-48h, fixed and stained to detect Podxl (red) and b-catenin (blue). Bar, 10 mm. (C) Confocal microscopy images of cysts stably expressing GFP-Slp2-a DC2AB. Cells were plated to form cysts for 12-24h, fixed and stained to detect Podxl (red) and b-catenin (blue). Bar, 10 mm. (D) Confocal microscopy images of cysts stably expressing GFP-Slp2-a C2A (left panels) and C2B (right panels). Cells were plated to form cysts for 12-24h, fixed and stained to detect Podxl (red) and b-catenin (blue). Bar, 10 mm. (E) Confocal microscopy images of cysts stably expressing a phosphatidylserine (PS) fluorescent probe (Lact-C2-GFP). Cells were plated to form cysts for 72h, fixed and stained to detect Podxl (red) and F-actin (blue). Note the lack of asymmetric polarization of PS at the PM. Bar, 10 mm. 
